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Abstract Duchenne muscular dystrophy (DMD) causes
cognitive impairment in one third of the patients, although
the underlying mechanisms remain to be elucidated. Recent
studies showed that mutations in the distal part of the
dystrophin gene correlate well with the cognitive impair-
ment in DMD patients, which is attributed to Dp71. The
study on the expression of the shortest isoform, Dp40, has
not been possible due to the lack of an isoform specific
antibody. Dp40 has the same promoter as that found in
Dp71 and lacks the normal C-terminal end of Dp427. In
the present study, we have raised polyclonal antibody
against the N-terminal sequence common to short isoforms
of dystrophin, including Dp40, and investigated the expres-
sion pattern of Dp40 in the mouse brain. Affinity chroma-
tography with this antibody and the consecutive LC-MS/MS
analysis on the interacting proteins revealed that Dp40 was
abundantly expressed in synaptic vesicles and interacted
with a group of presynaptic proteins, including syntaxin1A
and SNAP25, which are involved in exocytosis of synaptic
vesicles in neurons. We thus suggest that Dp40 may form a
novel protein complex and play a crucial role in presynaptic
function. Further studies on these aspects of Dp40 function
might provide more insight into the molecular mechanisms
of cognitive impairment found in patients with DMD.
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Introduction
Duchenne muscular dystrophy (DMD) is an X-linked
hereditary disease characterized by progressive muscular
degeneration. It is caused by mutations in the gene
encoding dystrophin that result in either the absence or
the dysfunction of dystrophin, a 427-kDa protein localized in
the plasma membrane of muscle cells [1]. In addition, about
one third of DMD patients manifest variable degrees of
cognitive impairment, which is not progressive in nature
and does not correlate with the severity of the muscular
disease [1–3]. A detailed neuropsychological study
showed that children with DMD have specific types of
learning disabilities, exhibiting significantly lower scores
in verbal memory and delays in reading and learning [4].
Although the brain is the organ showing most abundant
expression of dystrophin, next to muscle [5], the functions
of dystrophin in the brain remain to be elucidated. Two
alternative 427-kDa dystrophin isoforms, originating from
two distinct proximal promoters, are expressed in the cerebral
cortex and in the cerebellum [2, 3]: two smaller alternatively
spliced C-terminal products, 140-kDa dystrophin (Dp140)
and 71-kDa dystrophin (Dp71) [6]. The transcription of
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DOI 10.1007/s12035-012-8233-5Dp140 isinitiated upstreamfromexon45, and thatofDp71is
from between exon 62 and exon 63 [7]. Previous studies
indicated that point mutations in the Dp71 coding region
were closely associated with cognitive impairment observed
in DMD patients [8–11].
Dp40 is the shortest isoform of dystrophin identified
by sequencing of a cDNA clone isolated from a rat
Schwannoma library [12]( F i g .1). The 5'-UTR and the
sequence for the first seven amino acids are identical to
that of the 4.8-kb mRNA encoding Dp71, but the 3'-UTR
is derived from the intron 70 sequence. Dp40 is unique
since it lacks the normal C-terminal end of Dp427 (amino
acids 3409–3685) [7]. Since Dp40 has the same promoter as
that of Dp71, the expression of Dp40 might be affected
as well in DMD patients with mutations located in Dp71.
Daoud et al. reported that most of DMD patients with severe
mental retardation have mutations in exon 63–69 which in-
fluenced the expression of both Dp71 and Dp40 [10]. As
Dp40 is devoid of the common C-terminal regions, it is
expected that antibodies against common C-terminal regions
of all dystrophin isoforms are unable to recognize Dp40.
In order to understand the presumptive function of Dp40
in the brain, we have investigated what proteins interact
with Dp40 by using the novel antibody that we raised,
which enabled us to recognize the first 15 amino acids,
i.e., N-terminal sequences common to both Dp71 and Dp40.
The affinity chromatography and LC-MS/MS analysis
revealed that Dp40 interacted with a group of presynaptic
proteins, including syntaxin1A, SNAP25, and VAMP2, so
far known to be involved in exocytosis of synaptic vesicles
inneurons[13–15].TheselinesofevidencesuggestthatDp40
might play a crucial role in presynaptic functions in the brain.
Material and Methods
Animals
Eight-week-oldmaleICRmice were purchasedfroma breeder
(SHIMIZU Laboratory Supplies Co., Ltd., Kyoto, Japan).
All animal studies were approved by the Institutional
Review Board for Biomedical Research using Animals
at Kyoto Prefectural University of Medicine, and the
animals were handled according to the institutional guidelines
and regulations.
Antibodies
N-terminal Specific Antibody Against Short Isoforms
of Dystrophin
A polyclonal antibody against a synthetic peptide (MREQL
KGHETQTTCW,corresponding tothe first15amino acids of
Dp71 N-terminus: Dp71N) was raised in rabbit with a
conventional protocol (Iwaki, Japan). We will refer to
this antibody as N-terminal specific antibody against short
isoforms of dystrophin (N-term Ab). In order to confirm the
specificity of the N-term Ab, we used recombinant proteins
containing glutathione-S-transferase (GST) fused to Dp71N
expressed in Escherichia coli BL21 as well as the insect
cell line-expressed recombinant mouse Dp40 (kind gift of
Prof. H. Mori). Next, we attempted to detect the three short
isoforms of dystrophin in adult mouse whole brain lysate by
westernblot.Finally,weconfirmedwhetherthisantibodywas
applicable to the immunoprecipitation of the short isoform
proteins by using the aforementioned GST-fused protein.
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Fig. 1 The smaller alternatively spliced C-terminal products, 71-kDa
dystrophin (Dp71), 58-kDa dystrophin (Dp71Δ110; Dp58) and Dp40,
and the epitopes which the C-terminal anti-dystrophin antibody (Dys2)
and N-term Ab react are shown. Dp40 is the shortest isoform of
dystrophin, and the sequence for the first seven amino acids is identical
to that of the 4.8-kb mRNA encoding Dp71, but lacks the normal
C-terminal end of Dp427 (amino acids 3409–3685)
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A rabbit polyclonal antibody against syntaxin1A (ab41453,
abcam, MA, USA), a rabbit polyclonal antibody against
SNAP25 (ab5666, abcam, MA, USA), a rabbit polyclonal
antibody against VAMP2 (ab3347, abcam, MA, USA), a
mouse monoclonal antibody against SNAP25(SP12)
(ab24732, abcam, MA, USA), a mouse monoclonal
antibody against VAMP 1/2 (SP10) (sc-20039, Santa
Cruz Biotechnology, CA. USA ), a mouse monoclonal
antibody against syntaxin1 (HPC-1) (sc-12736, Santa
Cruz Biotechnology, CA. USA), a mouse monoclonal
antibody against synaptotagmin (MAB5202, CHEMICON/
Millipore, CA, USA), and a mouse monoclonal antibody
against CaMK II alpha (6 G9) (ab5683, abcam, MA, USA)
were used throughout the present study.
Secondary Antibodies
We employed anti-rabbit immunoglobulin antibodies
conjugated to horseradish peroxidase and anti-mouse
immunoglobulin antibodies conjugated to horseradish
peroxidase (GE Healthcare, UK), rabbit IgG TrueBlot
TM
HRP and mouse rabbit IgG TrueBlot
TM HRP (eBioscience,
San Diego, CA, USA), AlexaFluor
®647 goat anti-rabbit IgG,
AlexaFluor
®488 goat anti-mouse IgG, and AlexaFluor
®488
goat anti-mouse IgM (Invitrogen, Japan).
Immunoblot of Total Protein Extracts from Mouse Brain
Total protein extracts from various brain regions of the mouse
brain (cerebral cortex, hippocampus, thalamus, cerebellum)
were prepared by homogenizing in the extraction buffer (2%
sodium dodecyl sulfate (SDS), 62.5-mM Tris-HCl, pH6.8,
5% β-mercaptoethanol, 10% glycerol). One hundred μgo f
totalextractedproteinfromeachtissuewasseparatedbySDS-
PAGE and transferred to polyvinylidene difluoride (PVDF)
membrane. After blocking with 5% skim milk in TBS (20-
mM Tris, pH 7.5, 150-mM NaCl / 0.05% Tween-20), the
membrane was incubated with N-term Ab (dilution 1:1,000)
for1hatroom temperature (RT). Blots were incubated for
1 h at RT with anti-rabbit antibodies conjugated to horse-
radish peroxidase (dilution 1:1,000). Chemiluminescence
was detected using Super signal West pico (PIRECE, USA)
and BioMax XAR film (Kodak, Rochester NY, USA).
Immunohistochemistry of Mouse Brain and Muscle
Adult mice were transcardially perfused with 0.1-M
phosphate-buffered saline (pH 7.4, PBS). The brain and
gastrocnemius muscle were rapidly dissected; 10-μm-thick
frozen sections were prepared using cryomicrotome (Leica,
Wetzlar, Germany), mounted onto glass slides and fixed
with 2% paraformaldehyde for 5 min. After blocking,
they were incubated with N-term Ab (dilution; 1:1,000),
followed by FITC-conjugated goat anti-rabbit IgG (dilution;
1:1,000) as secondary antibody. Sections were observed
underafluorescencemicroscope(Nikon,Eclipse1000,Japan).
Subcellular Fractionation
The cerebral cortex and the hippocampus from 20 mice were
homogenized and fractionated as previously described [16].
Briefly, brains were homogenized in buffered sucrose
(320-mM sucrose, 4-mMHEPES-KOH, pH7.4)supplemented
with protease inhibitors. The homogenate was centrifuged
for 4 min at 3,340 rpm (1,100 g). The resulting pellet
(P1) was stocked, while the supernatant (S1) was collected
a n dc e n t r i f u g e df o r4m i na t9 , 6 6 0r p m( 9 , 2 0 0g ) .T h e
supernatant (S2) was pooled, and the pellet (P2) was washed
by re-suspending in buffered sucrose and re-centrifuged for
4minat10,170rpm(10,200g)toyieldasupernatant,S2',and
a pellet, P2'. The supernatant S2' and S2 were combined,
followed by centrifugation for 115 min in a Beckman 80Ti
rotor (Beckman Instrument Co., CA, USA) at 42,000 rpm
(165,000 g) to yield a pellet fraction P3 and a S3 (a cytosol
fraction). The pellet P2' was re-suspended in buffered sucrose
and was referred to a crude synaptosomal fraction. This
suspension was homogenized, and the resulting P2'-lysate
(L) was poured rapidly in 1-M HEPES-KOH buffer (pH 7.4)
on ice for 30 min. It was then centrifuged for 10 min at
16,300 rpm (25,000 g) to yield a lysate pellet (LP1) and a
lysate supernatant (LS1). The supernatant was collected and
centrifuged for 115 min in a Beckman 80Ti rotor at
42,000 rpm (165,000 g). The supernatants (LS2) and the
pellet (LP2) were pooled.
WGA Purification of LP2 Fraction
Synaptic vesicle fraction (LP2) from the hippocampus and
the cerebral cortex was lysed with solubilization buffer A
(20-mM HEPES (pH 7.4), 150-mM NaCl, 1-mM EDTA,
1% digitonin) and centrifuged at 22,000 g for 30 min, and
the pellet was lysed with solubilization buffer B (20-mM
HEPES (pH 7.4), 150-mM NaCl, 1-mM EDTA, 0.5% n-
dodecyl-β-D-maltoside (DDM)). The supernatant, after add-
ing 1-mM CaCl2 and 1-mM MgCl2, was loaded onto a
wheat germ agglutinin (WGA) sepharose column and incu-
bated overnight at 4°C. The first flow-through was collected
and stored. The column was washed with washing buffer
(20-mM HEPES (pH 7.4), 150-mM NaCl, 1-mM EDTA,
0.05% DDM). The binding proteins were eluted with the
elution buffer (N-acetylglucosamine 250 mM in washing
buffer). Equal amounts of protein lysates from the flow-
through and glycoprotein-enriched samples, after precip-
itating with ProteoExtract
® (Calbiochem, Germany), were
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brane. Immunoreactive bands for β-dystroglycan and Dp40
were visualized using Super signal West pico.
Immunoaffinity Chromatography for LC-MS/MS Analyses
Protein G agarose beads cross-linked with the N-term Ab by
DMP (dimethyl pimelimidate-2 HCl) were incubated with
the WGA flow-through fraction overnight at 4°C. The beads
were put into the mini column and washed with washing
buffer (20-mM HEPES(pH 7.4), 0.05% DDM, 150-mM
NaCl, 1-mM EDTA). The binding fraction was eluted with
peptide-containing elution buffer (100 μg/ml of the antigen
peptide, i.e., N-terminal 14 amino acids (MREQLK-
GHETQTTCW) specific to the short isoform dystrophin in
washing buffer). The eluted fractions were precipitated using
ProteoExtract® Protein precipitation kit (Merk, Japan). The
dissolved pellet was separated by SDS-PAGE and stained by
silver staining kit (Wako, Japan). The high-intensity protein
bands were cut out from the gel, followed by LC-MS/MS
analysis (Apro Life Science Institute Inc, Japan). The Mascot
scores were obtained from Mascot searches (Matrix science),
and the Mascot default significance threshold of p<0.05 for
assignments was used in this study. The rest of the fractions
were separated by SDS-PAGE and transferred to the PVDF
membrane. Immunoreactive bands for Dp40, syntaxin1A,
SNAP25, VAMP2, synaptotagmin, and CaMK II were visu-
alized using ECLWestern Blotting Detection System.
Immunoprecipitation
A Dp40-enriched LP2 fraction purified by WGA (300-μg
protein) was preincubated with 50 μl of anti-rabbit IgG
beads (eBioscience, SanDiego, USA) for 30 min at 4°C.
Beads were eliminated by centrifugation, and extracts were
incubated with 2–10-μg immunoprecipitating antibody for
1 h at 4°C. Fresh 50 μl of IgG beads was added to the
sample and incubated overnight at 4°C. Immunoprecipitated
beads were washed with washing buffer (20-mM HEPES
(pH 7.4), 150-mM NaCl, 1-mM EDTA, 0.5% DDM), solubi-
lized in the sample buffer, and heated to 95°C for 10 min. The
proteins within the immunoprecipitated complexes were then
separated by SDS-PAGE and identified by specific primary
antibodies as described previously.
Cell Culture of Hippocampal Neurons
and Double Immunofluorescence Study
Primary hippocampal neurons were prepared as follows:
hippocampi dissected from mouse brains at embryonic day
17.5 (E17.5) were dissociated and plated onto 12-mm-
diameter glass coverslips precoated with poly-D-lysine and
laminin at a density of 1×10
4 cells/cm
2. Cultures were
maintainedinNeurobasalmedium(Invitrogen,Japan)supple-
mented with 2% B27 (GIBCO, Invitrogen, Japan) and
0.5-mML-glutamine(GIBCO, Invitrogen, Japan)asdescribed
elsewhere [17]. The hippocampal neurons were cultured
for 10 days in 24-well plates and then fixed with acetone/
methanol (1:1) for 15 min on ice. After blocking, cells were
sequentially incubated with the following primary antibodies
overnight at 4°C. At first, cells were incubated with N-term
Ab (dilution 1:100), followed by AlexaFluor546
®-conjugated
goat anti-rabbit IgG as secondary antibody. Subsequently,
cells were incubated with Dys2 (dilution 1:100) and anti-
synaptic markers such as syntaxin1 (1:50), SNAP25
(1:1000), VAMP1/2 (1:100), synaptotagmin (1:500), CaMK
II alpha (1:500), and PSD95 (1:500), respectively. Cells were
incubated with secondary antibodies, AlexaFluor
®488-
conjugated goat anti-rabbit IgG, and AlexaFluor
®647-
conjugated goat anti-mouse IgG at 1:1,000 for 1 h. After
washing, cells were mounted with SlowFade
® (Invitrogen,
Japan).Thespecimenswereobservedandphotographedunder
a confocal laser microscope (FV-1000, OLYMPUS, Japan).
Image Analysis
In order to evaluate co-localization of DP-40 and presynap-
tic markers such as syntaxin1A, SNAP25, VAMP2, synap-
totagmin, and synaptophysin as well as a postsynaptic
marker, PSD 95, on neurites, we performed morphometrical
analyses (Adobe photoshop CS53 EXTENDED ver 10.0.1)
(Online Resource 3). We measured every pixel showing
immunofluorescence after binarization of digital images
and calculated ratios of target areas. Target areas included:
singly immunoreactive for N-term Ab (I, indicated by red
fluorescence), C-terminal dystrophin, Dys2 (II, indicated by
green fluorescence), and different synaptic markers (III,
indicated by blue fluorescence); double immunoreactive for
Dys2 and different synaptic markers (IV, indicated by light blue
fluorescence), N-term Ab and different synaptic markers (V,
indicated by pink fluorescence), and N-term Ab and Dys2 (VI,
indicated by yellow fluorescence); and triply immunoreactive
for N-term Ab, Dys2, and different synaptic markers (VII,
indicated by white fluorescence). The areas immunoreactive
for both of N-term Ab and different synaptic markers without
immunoreactivity for Dys2 indicate presynaptic areas showing
co-localization of DP-40 and presynaptic molecules.
Results
Confirmation of the Specificity of the Anti-N-terminal
Specific Antibody (N-term Ab)
The rabbit polyclonal antibody was raised to the peptide
carrying the N-terminal sequence common among Dp71,
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was then evaluated. First, we performed the immunochemical
detection of the recombinant GST with the antigen peptide
sequence at the N-termini. The antibody successfully reacted
with the antigen-fused GST but not GST itself (data not
shown). The antibody was also reacted with the insect cell
line-expressed recombinant mouse Dp40 as a 34.2-kDa band
(Fig. 2a). In these experiments, the antigen absorption
inhibited the detection of all of the recombinant proteins.
We detected immunochemically three short isoforms of
dystrophin in adult mouse whole brain lysate; apparent
molecular weight 69.4, 47.1, and 34.2 kDa, respectively
(Fig. 2b). These major bands are thought to correspond to
mouse Dp71, Dp58, and Dp40, respectively, because the
molecular weight of the fastest migrating band is consistent
with the one of the aforementioned recombinant Dp40
(Fig. 2a)[ 18, 19]. These proteins were not detected with
the antigen-preabsorbed antibody. The 69.4-kDa band was
detected as two split bands (69.4 and 65.1 kDa) when the
amount of loaded sample was adjusted. Two split bands of
Dp71 were considered to correspond to the Dp71 isoforms
with long or short C-terminal sequence that was produced
by alternative splicing. The apparent 140.9-kDa protein
band (indicated by open arrowhead in Fig. 2b) was seldom
reproducible. This band may correspond to another isoform
Dp140 expressed in the brain because the preabsorbed
antibody failed to detect it and because the C-terminal
sequence of the antigen peptide is common among all
isoforms of dystrophin. It is, however, noteworthy that
this band was seldom detected reproducibly in western
blot and never in the following affinity purification
experiments. Taken together, these results suggest that
the reactivity of our antibody is highly specific towards
the three short isoforms of dystrophin.
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Fig. 2 Short isoforms of dystrophin were detected by western blot
analyses and immunohistochemistry using the N-term Ab. a The N-term
Ab reacted with the insect cell line-expressed recombinant mouse
Dp40 as a 34.2-kDa band (arrowhead). b Three major bands were
detected with apparent molecular weight 69.4, 47.1, and 34.2 kDa,
respectively, in adult mouse whole brain lysate. c The GST-fused
antigen protein but not GST itself was successfully precipitated with the
N-term Ab. d Immunoreactivity for short isoforms of dystrophin (green)
was observed in the perivascular area and glia limitans, being composed
of astrocytic foot processes, in the cerebellum. Scale bar050 μm.
e Immunoreactivity for 427-kDa dystrophin (green) was localized
in the sarcolemma of skeletal muscle. Scale bar025 μm
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precipitation of the short isoform proteins because the
GST-fused antigen protein but not GST itself was
successfully precipitated with the antibody. This reaction
was prevented by the preabsorption with the peptide
(Fig. 2c).
Immunofluorescent signals were observed in the perivas-
cular astrocytic endfeet localized in the granular and
molecular layer of the mouse cerebellum as well as in
the glia limitans (Fig. 2d). This expression pattern was
consistent with previous reports [20]. In skeletal muscles,
dystrophin-immunofluorescence was localized in the
sarcolemma, which showed that N-term Ab recognized
the 427-kDa dystrophin of the muscle at the common
regions of dystrophin (Fig. 2e).
Taken together, our antibody is considered to be highly
specific towards three short isoforms of dystrophin, and it is
thus applicable to immunoprecipitation experiments in
addition to immunochemical and immunohistochemical
detection.
Biochemical Characterization and Subcellular Localization
of Dp40 in Mice Brain Extracts
Dp40 showed two distinct biochemical characteristics
different from Dp58 and Dp71. The first was that Dp40
had a unique detergent solubility different from other
short isoforms of dystrophin. Dp40 was insoluble in
digitonin, although it is soluble in DDM and TritonX-100.
On the other hand, Dp71 and Dp58 were soluble in all of the
three detergents which we employed, including digitonin,
DDM, and TritonX-100 (Fig. 3a). Therefore, this distinct
solubility in detergents allowed us to separate Dp40 from
other two short isoforms of dystrophin. The second was that
Dp40 showed a lower affinity to lectin, WGA. In order to
analyze the interaction between Dp40 and glycosylated
molecules so far known to form a dystrophin glycoprotein
complex (DGC), we adopted WGA affinity column chro-
matography. It turned out that although both Dp71 and
β-dystroglycan were detected in the WGA-bound frac-
tion as reported previously [21], Dp40 was detectable in
the WGA-unbound fraction (Fig. 3b). In addition, Dp58
was found in the WGA-bound fraction (data not shown).
The low affinity between Dp40 and DGC led us to
hypothesize that Dp40 might form a novel protein com-
plex different from DGC. The DGC was already known
to be composed of other short isoforms of dystrophin,
which were abundantly expressed in neuronal cells, such
a sD p 7 1a n dD p 5 8[ 6]. As for subcellular localization of
short isoforms of dystrophin, our studies revealed that
Dp40 was enriched in the LP2 fraction (synaptic vesicle
fraction) and Dp71 was present in similar membrane
fractions, as previously described [5, 22]. Dp58 was
enriched in soluble fractions (Fig. 3c). We therefore
d e c i d e dt ou s et h eL P 2f r a c t i o nt os e p a r a t eD p 4 0a n d
Dp71 from Dp58. Our procedure to obtain the Dp40-enriched
protein extract was as follows: (1) After collecting the LP2
fraction of mouse cerebral cortex and hippocampus, the
insoluble fractions of LP2 were eluted first with 1%
digitonin, followed by elution with 0.5% DDM, (2) the
soluble DDM fractions were applied to WGA column,
and the WGA-unbounded fractions were collected.
Dp71
Dp58
Dp40
Dig
Dig
DDM
Dig
DDM
Tx
Dp71
Dp58
Dp40
H S1 P1 S2 P2 S2’ P2’ S3 P3 LS1 LP1 LS2 LP2
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b
Fig. 3 Subcellular localization
and biochemical characterization
of Dp40 was demonstrated using
the N-term Ab. a Dp40 was
insoluble in 1% digitonin (Dig)
and soluble in 0.5% DDM,
as shown in Dig⇢DDM and
1% Tx (TritonX-100; as shown
in Dig⇢DDM⇢Tx). Dp71 and
DP58 (Dp71Δ110) were soluble
in digitonin, DDM, and Tx.
b WGA affinity chromatography
showed that Dp40 was detected
in the WGA-unbound fraction
(F.T flow-through) not inE1, E2,
and E3 (E elute; WGA-bound
fraction). W wash fraction.
c Subcellular fractionation
revealed that Dp40 and Dp71
wereenrichedintheLP2fraction
(synaptic vesicle fraction),
whereas DP58 was enriched
in soluble fractions (S3)
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by Immunoaffinity Column and LC-MS/MS
The Dp40-enriched fraction was applied to immunoaffinity
column composed of protein G agarose beads cross-linked
with the N-term Ab against short isoforms of dystrophin,
and bound fractions were then separated by SDS-PAGE.
The intensely stained bands of smaller than 60 kDa
(indicated as *1, *2, *3 in Fig. 4a) were cut and processed
for the analysis with LC-MS/MS (Apro Life Science Institute
Inc, Japan). Proteins identified by LC-MS/MS analysis were
listed in Table 1. Syntaxin1A and SNAP25 (synaptosome-
associated protein of 25 kDa) were identified with high
Mascot score, and the other vesicle trafficking proteins
were also detected. Immunoblot analysis confirmed that
Dp40 interacted with the SNARE complex, which included
syntaxin1A, SNAP25, and VAMP2 (vesicle-associated
membrane protein 2, also called synaptobrevin). In addition,
theothervesicletraffickingproteins,includingsynaptotagmin
and CaMK II, were shown to interact with Dp40 (Fig. 4b).
Co-immunoprecipitation with Presynaptic Proteins
To validate the complex analysis described previously,
Dp40-enriched extracts from LP2 fractions were subjected
to immunoprecipitation studies with the N-term Ab. It
turned out that SNARE complex proteins such as syntax-
in1A, SNAP25, and VAMP2 were co-immuoprecipitated
with Dp40, but not with normal preimmune rabbit IgG
(Fig. 5a). Reciprocal immunoprecipitation studies revealed
that syntaxin1A and SNAP25 interacted similarly with
Dp40 in LP2 fractions (Fig. 5b), which suggests that Dp40
might play some functional role in the presynaptic terminal,
including exocytotic vesicle docking or fusion with the
plasma membrane.
For further analysis of the molecular components of the
complex, Dp40-enriched fractions of LP2 were loaded onto
a continuous 3–20% sucrose gradient and centrifuged for
16 h at 140,000 g. Fourteen fractions were separately
collected and analyzedbywestern blot(Online Resource1A).
In Dp40-enriched fraction, VAMP 2 was not enriched, and
similarly Dp40 was not highly enriched in VAMP2-enriched
fractions. The Dp40-enriched fraction was subjected to
immunoprecipitation with the N-term Ab. It turned out
that SNARE complex proteins such as syntaxin1A,
SNAP25, and VAMP2 were co-immuoprecipitated with
Dp40; however, reciprocal immunoprecipitation with
VAMP2 demonstrated that VAMP2 did not interact with
Dp40 (Online Resource 1B).
Co-localization of the Short Isoform Dystrophin
with Presynaptic Proteins in Cultured Hippocampal
Neurons
We studied whether Dp40 was co-localized with presynaptic
proteins in primary cultured mouse hippocampal neurons
using triple immunofluorescence techniques (Fig. 6). The
immunofluorescence for the N-term Ab showed a fine
punctate pattern along the dendrites (red fluorescent signals,
Fig. 6, Online Resource 2), which was consistent with
previous reports [21]. Using confocal microscopy, we
confirmed that some of the puncta exhibited co-localized
immunostaining for the N-term Ab (indicated by red
fluorescence) and for syntaxin1A (blue fluorescence, Fig. 6a),
SNAP25 (blue fluorescence, Fig. 6b), VAMP2 (blue fluores-
cence, Fig. 6c), CAMK II (blue fluorescence, Fig. 6d),
synaptotagmin (blue fluorescence, Fig. 6e), and synapto-
physin (blue fluorescence, Fig. 6f). It was thus concluded
that the short isoform of dystrophin was expressed at
some synaptic boutons present on both somata and
axons. We could demonstrate that there were areas show-
ing immunoreactivity for N-terminal short isoform of dystro-
phin and different synaptic markers and negative for C-
terminal dystrophin, which indicatedco-localizationof DP-
40 and some synaptic molecules. The areas were 11.6±
4.4% in syntaxin1, 15.0±4.1% in SNAP25, 23.7±6.9% in
VAMP 1/2, 12.7±6.6% in CaMK II, 8.7±10.6% in syn-
aptotagmin, 6.4±3.7% in synaptophysin, and 7.7±6.0% in
PSD95 (Online Resource 3). A few DP-40 puncta existed not
only in the presynapse but also in the postsynapse. How-
ever, DP-40 was co-localized more specifically with pre-
synaptic markers such as syntaxin1, SNAP25, and VAMP
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Fig. 4 Purificationwithaffinitychromatographyenabledtheisolationof
spotsforLC-MS/MS,andimmunoblotanalysisrevealedaninteractionof
Dp40 with the SNARE complex. a The elution samples were run on
SDS-PAGE and stained with a Wako silver staining kit. Right lane is
control (without treatment with the antibody). The bands *1,*2, and
*3 were cut out for LC-MS/MS analysis. b Immunoblot analysis
revealed that SNARE complex proteins such as syntaxin1A, SNAP25,
and VAMP2 were detected and that other vesicle trafficking proteins,
including synaptotagmin and CaMK II, were also detected with Dp40,
although at lower levels
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LC-MS/MS.
Discussion
In the present study, we attempted to raise a polyclonal
antibody against the N-terminal sequence common to
three short isoforms of dystrophin and confirmed that
the antibody actually recognized three isoforms, including
Dp71, Dp58 (Dp71Δ110), and Dp40. It is worth noting
that Dp40 was abundantly expressed in the brain and
enriched in the synaptic vesicle fraction as assessed by
subcellular fractionation. Furthermore, we demonstrated
two biochemical characteristics of Dp40; firstly, Dp40
showed a detergent insolubility different from Dp71 and
Table 1 Proteins identified by LC-MS/MS of excised and trypsin-digested gel bands
Gel band Accession no. Description Source Mascot score Unique peptide matched
*1 gi 13542680 Tublin, beta 2 C Mus musculus 823 17
gi 6755901 Tublin, alpha 1 Mus musculus 783 15
gi 39104626 mKIAA0968 protein Mus musculus 269 5
*2 gi 15011853 Syntaxin 1A Mus musculus 1,024 24
gi 21746161 Tublin, beta Mus musculus 193 4
gi 14715019 Syntaxin 12 Mus musculus 60 1
*3 gi 6755588 Synaptosomal-associated protein 25 Mus musculus 908 26
gi 6679593 Ras-related protein Rab-3A Mus musculus 99 1
gi 4731936 Synaotogyrin 3 Mus musculus 77 1
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Fig. 5 The SNARE complex was co-immunoprecipitated with Dp40
when using the WGA-unbound LP2 fraction of brain lysate. a The
lysate from Dp40-enriched LP2 fraction was immunoprecipitated with
N-term Ab or normal preimmune rabbit IgG. SNARE complex such as
syntaxin1A, SNAP25, and VAMP2 were co-immunoprecipitated by
forward immunoprecipitation. b Same samples were used for reverse
immunoprecipitation. Inp input, UB unbound fraction, B bound
fraction
294 Mol Neurobiol (2012) 45:287–297Dp58, and secondly, Dp40 interacted poorly with β-
dystroglycan which has been regarded as a main compo-
nent of the DGC, while previous reports indicated that
Dp71 and Dp58 interacted with β-dystroglycan at the
c y s t e i nr i c hd o m a i n[ 23, 24]. These observations led us
to hypothesize that Dp40 might form a novel protein
complex different from DGC. Affinity chromatography
and LC-MS/MS analysis revealed that the components
of this protein complex with Dp40 were presynaptic
proteins, such as syntaxin1A and SNAP25. To our
knowledge, this is the first report to show that Dp40
interacted with a group of presynaptic proteins, and our
observation should provide a new insight into understanding
the function of Dp40 in the brain.
A possible relationship between the intellectual impair-
ment and the altered expression of the C-terminal short
isoforms of dystrophin in the brain has been discussed in
previous case reports [25, 26]. Some reports suggested that
Dp71 deficiency was associated with mental retardation
(MR) in a subpopulation of DMD patients [8, 10], and the
deficiency was considered to contribute to the severity of the
MR phenotype. It was reported that patients with severe MR
had mutations which influenced the expression not only of
Dp71 but also of Dp40, although nothing was mentioned
about the expression of Dp40 in those patients [10]. This
observation prompted us to hypothesize that Dp40 might
have novel functions in the brain which are relevant to
cognitive function. Daoud et al. demonstrated that Dp71-
associated protein complexes interacted with specialized
modular scaffolds that enabled glutamate receptors to
cluster and to organize signaling cascades in postsynaptic
densities [27]. They further showed that Dp71-null mice
displayed abnormal synaptic organization and maturation
invivo, namely, abnormallyenhancedglutamate transmission
and altered synaptic plasticity in the CA1 area of the
hippocampus. Since Dp71-null mice were deficient in not
only Dp71 but Dp40 [28], the alteration of glutamate
release might be caused by loss of both Dp71 and
Dp40. Our present investigation clearly demonstrates that
Dp40 has an interaction with a group of presynaptic
proteins, such as syntaxin1A and SNAP25. Thus, it
w o u l db er e a s o n a b l et oe x p e c tt h a tD p 4 0m a yp l a ya
c b a
f e d
Fig. 6 Co-localization of short isoforms of dystrophin and presynaptic
proteins in primary cultured mouse hippocampal neurons. Primary
cultured hippocampal neurons were sequentially triply immunostained
with the rabbit N-term Ab (red), rabbit antibody against C-terminal
dystrophin (green), and with mouse antibodies against presynaptic
proteins including syntaxin1 (a), SNAP25 (b), VAMP 1/2 (c), CaMK II
(d), synaptotagmin (e), or synaptophysin (f)( blue). Short isoforms of
dystrophin were focally co-localized with presynaptic proteins at
apparent synaptic boutons (purple). Scale bar030 μm
Mol Neurobiol (2012) 45:287–297 295crucial role in presynaptic function because syntaxin1A
and SNAP25 are involved in regulating exocytosis of
synaptic vesicles in neurons. It is worth noting that
ablation of syntaxin1A in mice induced abnormal behavior
by disrupting serotonergic systems [29].
At present, some issues still remain to be resolved.
Although our analysis by affinity chromatography showed
that Dp40 mainly interacted with SNARE (soluble N-ethyl
maleimide sensitive factor attachment protein receptors)
complex proteins such as syntaxin1A, SNAP25, and
VAMP2, the reciprocal immunoprecipitation failed to
demonstrate that VAMP2 did interact with Dp40. These
paradoxical results might be due either to the possibility
that the epitope of VAMP2 recognized by anti-VAMP2
antibody may overlap with or be in close proximity to
the site that interacts to Dp40 or, alternatively, that the
fraction of VAMP2, showing close association with
Dp40, was below the sensitivity for detection. However,
w ec l e a r l yd e m o n s t r a t e dw i t hi m m u n o h i s t o c h e m i s t r yt h a t
VAMP2 was co-localized at least in part with short isoforms
of dystrophin, including Dp40, when examined in cultured
hippocampal neurons. The currently established concept of
the SNARE complex includes VAMP2 [15]. Taken together,
we thus concluded that VAMP2 was a candidate protein
which interacted with Dp40 in the presynaptic site. But, there
still remains some possibility that Dp40 protein complex
exists as a different pool from the SNARE complex in the
presynapse. Ohyama et al reported that CaMK II interacted
with syntaxin1A and SNAP25 but not withVAMP2 [30]. Our
resultsthatCaMKIIwasdetectableasaninteractingmolecule
withDp40byLC-MS/MSandimmunoblotanalysesmayalso
support their notion. The prominent nuclear staining was
found in hippocampal neurons with both the N-term- and
C-term- antibodies (ESM 2), which might be reactive to
short isoforms of dystrophin such as Dp58 and Dp71. As
nuclear localization and nuclear function have been already
described forDp71[31,32],itispertinenttotakeintoaccount
that Dp40 might have nuclear localization and a putative
nuclear function.
The function of other brain dystrophin isoforms
(Dp427, Dp140) has as yet been fully understood, al-
though loss of those isoforms were reported to be associ-
ated with cognitive impairment [33, 34]. However, at
present, it is difficult to conclude which defect, the defects
in full-length dystrophin and/or in the shorter isoforms,
may contribute to the development of cognitive impair-
ment. It is worth stating that SNAREs are not only in-
volved in steps of docking and fusion of synaptic vesicles
to the active zone, but that they also play an important
role in the Ca
2+-triggering step itself [35]. Further experi-
ments are required to address the important question of
the molecular mechanisms of cognitive impairment in
DMD patients.
In conclusion, we have shown here the expression and
the protein interactions of the shortest isoform of dystrophin
Dp40 in the mouse brain and demonstrated that Dp40 is a
novel molecule assembling a group of presynaptic proteins
especially involvedin exocytosis.In order to betterunderstand
the functions of Dp40 in the brain, our laboratories are
currently studying with siRNA silencing as well as Dp40
conditional knockout mice.
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